Novartis income drops 42 pct in Q3 after sale a year earlier
Swiss pharmaceutical giant Novartis says net income fell 42 percent in the third quarter, largely due to the sale of its hepatitis drug unit a year earlier and provisions for legal settlements and fees.
Oct 27, 2015